H.R.413
Congress: 113th
Sponsor: Representative Welch, Peter (01/23/2013)
Committees: House - Energy and Commerce; Ways and Means
Description: To eliminate the 2-year delay in including oral-only ESRD-related drugs in the Medicare ESRD prospective payment system, as provided under section 632(b)(1) of the American Taxpayer Relief Act of 2012.
Vote Result:
Lastest Action: 02/08/2013 Referred to the Subcommittee on Health. (All Actions)
Official: H.R.413 -- 113th Congress
- 0 Comments